Gossamer Bio, Inc.

Gossamer Bio is a drug development company working on treatments for pulmonary hypertension and pulmonary arterial hypertension, conditions where blood pressure in the lungs becomes dangerously high. The company's main candidate is GB002, an inhaled drug that blocks certain proteins involved in these diseases, currently being tested in late-stage human trials. Gossamer licensed the drug from another company and is based in San Diego.